All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
CAR-CQ0606 | Anti-COX5A (CBXC-0533) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBXC-0533 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-CQ4030 | Anti-COX5A (CBXC-0533) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBXC-0533 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY2941 | Anti-COX5A (CBFYC-2122) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2122 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WFY6194 | Anti-COX5A (CBFYC-2122) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBFYC-2122 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0550 | Anti-COX5A (CBWJC-2975) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-2975 | Mouse | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0551 | Anti-COX5A (CBWJC-2976) h(41BB-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-2976 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ0552 | Anti-COX5A (CBWJC-2977) h(41BB-CD3ζ) CAR, pCDCAR1 | CBWJC-2977 | Rabbit | scFv-41BB-CD3ζ | Lentiviral vector | T cell | |||
CAR-WJ2842 | Anti-COX5A (CBWJC-2975) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-2975 | Mouse | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2843 | Anti-COX5A (CBWJC-2976) h(CD28-CD3ζ) CAR, pCDCAR1 | Human | CBWJC-2976 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell | ||
CAR-WJ2844 | Anti-COX5A (CBWJC-2977) h(CD28-CD3ζ) CAR, pCDCAR1 | CBWJC-2977 | Rabbit | scFv-CD28-CD3ζ | Lentiviral vector | T cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION